Preferred Label : leuprolide acetate;
UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T125 - Hormone;
CAS number : 88793-81-1; 37JNS02E7V;
Is substance : O;
UNII : 37JNS02E7V;
InChIKey : RGLRXNKKBLIBQS-XNHQSDQCSA-N;
Origin ID : M0329431;
UMLS CUI : C0700596;
CISMeF manual mappings
- Related record
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3445467/fr/leuproreline-zentiva-leuproreline-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug implants
Hormone sensitive prostate cancer (disorder)
leuprolide acetate
antineoplastic agents, hormonal
leuprorelin
evaluation of the transparency committee
prostatic neoplasms
leuprolide
---
https://www.has-sante.fr/jcms/p_3399894/fr/enantone-lp-leuproreline-puberte-precoce-centrale
2022
false
false
false
France
Delayed-Action preparations
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
leuprolide acetate
Product containing only leuprorelin in parenteral dose form (medicinal product form)
evaluation of the transparency committee
leuprolide
precocious puberty, central
puberty, precocious
---
https://www.has-sante.fr/jcms/p_3322982/fr/zeulide-leuproreline
2022
false
false
false
France
leuprolide acetate
leuprolide acetate
insurance, health, reimbursement
treatment outcome
leuprorelin
prostatic neoplasms
neoplasms, hormone-dependent
palliative care
advanced hormone-dependent prostate cancer
fibroid uterus
endometriosis
puberty, precocious
breast neoplasms
premenopause
antineoplastic agents, hormonal
Product containing only leuprorelin in parenteral dose form (medicinal product form)
evaluation of the transparency committee
leuprolide
---
https://ansm.sante.fr/tableau-marr/acetate-de-leuproreline
2021
false
false
false
France
French
guidelines for drug use
drug compounding
leuprolide acetate
antineoplastic agents, hormonal
injections, subcutaneous
leuprorelin
leuprolide
---
https://www.has-sante.fr/jcms/p_3159944/fr/leptoprol
2020
false
false
false
France
leuprolide
leuprolide acetate
leuprorelin
prostatic neoplasms
neoplasms, hormone-dependent
antineoplastic agents, hormonal
drug implants
insurance, health, reimbursement
treatment outcome
radiotherapy
prostatic neoplasms
neoplasms, hormone-dependent
evaluation of the transparency committee
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/zeulide-depot-cancer-prostate-5136.html
2020
false
false
false
Canada
French
drug evaluation
leuprolide acetate
prostatic neoplasms
leuprolide
---
Eligard (leuprolide acetate): Reconstitution and administration errors and risk of
lack of efficacy
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2017-01-page2-fra.php#mae
2017
false
false
false
Canada
French
English
drug compounding
pharmacovigilance note
canada
leuprolide acetate
medication errors
injections, subcutaneous
Incorrect route of drug administration
Delayed-Action preparations
prostatic neoplasms
Inappropriate reconstitution technique
Product preparation error
leuprorelin
leuprolide
---
https://www.has-sante.fr/portail/jcms/c_2772599/fr/leptoprol
2017
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
Prefilled Syringe Dosage Form
leuprolide acetate
drug implants
leuprorelin
antineoplastic agents, hormonal
insurance, health, reimbursement
neoplasms, hormone-dependent
prostatic neoplasms
Advanced Malignant Neoplasm
palliative care
injections, subcutaneous
leuprolide
---
